Morning Market Movers By: Benzinga via Benzinga October 22, 2014 at 09:42 AM EDT Regulus Therapeutics (NASDAQ: RGLS) shares climbed 94.39% to $13.16 following the announcement of positive RG-101 study data. Unisys ... Read More >> Related Stocks: Aware Inc Broadcom Corp Irobot Corp Regulus Therapeutics Six Flags Entertainment Corp Stanley Black & Decker Unisys Corp Xerox Corp